OpenCapital
Beta
Calendar
Stocks
Metrics
Connect AI
/
Stocks
Portfolio
Sign In
Toggle navigation menu
Stocks
MDL
Medline, Inc.
Balance Sheet Statement
2023
Discontinued — last reported Q2 '22
Other
2023
Export Chart
Analysis
Statement
Balance Sheet Statement
Section
Other
First reported
Q2 2022
Last reported
Q2 2022
Metric ID:
other_recorded_unconditional_purchase_obligation_due_wit_8853cf
Historical Data
1 periods
Quarterly
Q1 '26
Value
$162.00M
Frequently Asked Questions
What is Medline, Inc. 's 2023?
Medline, Inc. (MDLN) reported 2023 of $162.00M in Q1 2026.